These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35875673)

  • 21. Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival.
    Zhang M; Lv X; Jiang Y; Li G; Qiao Q
    Exp Ther Med; 2019 Sep; 18(3):2140-2152. PubMed ID: 31452706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
    Lu WC; Xie H; Yuan C; Li JJ; Li ZY; Wu AH
    Cancer Cell Int; 2020; 20():419. PubMed ID: 32874133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
    Wang K; Huang R; Tong X; Wang Z; Sun S; Wu C
    Biomed Res Int; 2021; 2021():5579359. PubMed ID: 34373835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme.
    Zhang X; Jin S; Shi X; Liu S; Li K; Liu G; Zhong S; Liu T; Li L; Tao S; Zhai Q; Bao N; Ren L; Wu Y; Bao Y
    Front Pharmacol; 2022; 13():898679. PubMed ID: 35571123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
    Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
    Front Oncol; 2020; 10():590352. PubMed ID: 33392085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis.
    Wang J; Yan S; Chen X; Wang A; Han Z; Liu B; Shen H
    Technol Cancer Res Treat; 2022; 21():15330338211035270. PubMed ID: 35538679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme.
    Aisa A; Tan Y; Li X; Zhang D; Shi Y; Yuan Y
    Front Oncol; 2022; 12():911942. PubMed ID: 35860560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 33. A 4-gene panel predicting the survival of patients with glioblastoma.
    Guo XX; Su J; He XF
    J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
    Prasad B; Tian Y; Li X
    Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
    Wang LJ; Lv P; Lou Y
    Front Oncol; 2022; 12():862723. PubMed ID: 35574375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
    Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
    Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Extracellular Matrix Gene-Based Prognostic Model to Predict Overall Survive in Patients With Glioblastoma.
    Qian C; Xiufu W; Jianxun T; Zihao C; Wenjie S; Jingfeng T; Kahlert UD; Renfei D
    Front Genet; 2022; 13():851427. PubMed ID: 35783254
    [No Abstract]   [Full Text] [Related]  

  • 40. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.